Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Howard WestDavid R Gandara

Abstract

Advanced bronchioloalveolar carcinoma (BAC) is a distinct subtype of non-small-cell lung cancer (NSCLC) for which there is currently no optimal therapy. Based on preclinical and clinical data suggesting relevance of the epidermal growth factor receptor (EGFR) axis in BAC, the Southwest Oncology Group initiated a phase II trial (S0126) to evaluate the EGFR tyrosine kinase inhibitor gefitinib in chemotherapy-naïve and chemotherapy-pretreated patients with advanced BAC. A total of 136 eligible and assessable patients (101 untreated, 35 previously treated) received gefitinib 500 mg daily until progression or prohibitive toxicity. The median age was 68.0 years (range, 34.3 to 88.6); 51% were female; 89% had a performance status (PS) of 0% or 1% and 11% had a PS of 2. The Response Evaluation Criteria in Solid Tumors response rate was 17%, with 6% complete responses (CRs) among 69 previously untreated patients with measurable disease, and 9% with no CRs among 22 pretreated patients. Median survival was 13 months for both chemo-naïve (95% CI, 8 to 18) and previously treated patients (95% CI, 6 to 17). Overall survival at 3 years was 23% (95% CI, 14% to 32%). Toxicity consisted mainly of rash and diarrhea, but 2% of patients died of pre...Continue Reading

References

Aug 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J E Barkley, M R Green
May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaJosé Baselga
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vincent A MillerRobert T Heelan
Jun 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David R GandaraWilbur A Franklin
Aug 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Román Pérez-SolerPhilip Bonomi
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Oct 13, 2004·Clinical Lung Cancer·Bradley S SabloffJeremy J Erasmus
Apr 30, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H L WestUNKNOWN Southwest Oncology Group
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group

❮ Previous
Next ❯

Citations

Jun 2, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mario E LacoutureUNKNOWN MASCC Skin Toxicity Study Group
Jun 26, 2007·Current Oncology Reports·Rosalyn Juergens, Julie Brahmer
Aug 18, 2006·Nature Reviews. Cancer·Andrea H BildJoseph R Nevins
Jun 2, 2009·Nature Reviews. Clinical Oncology·Helena LinardouSamuel Murray
Oct 4, 2006·Nature Reviews. Drug Discovery·Christopher A McCullochHani El-Gabalawy
Aug 7, 2009·Anti-cancer Drugs·Yuri RukazenkovAlan Swaisland
Aug 8, 2009·Respirology : Official Journal of the Asian Pacific Society of Respirology·Seiichi KobayashiMasaru Yanai
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David M JackmanBruce E Johnson
Jun 10, 2010·Biologics : Targets & Therapy·Vamsidhar VelchetiRamaswamy Govindan
Jun 10, 2010·Drug Design, Development and Therapy·M TiseoP Bordi
May 1, 2012·Archives of Pathology & Laboratory Medicine·Philip T Cagle, Lucian R Chirieac
Jun 11, 2011·Journal of Biomedicine & Biotechnology·Raffaele CostanzoAlessandro Morabito
Oct 5, 2010·Annual Review of Pathology·Gilda da Cunha SantosMing Sound Tsao
Oct 1, 2007·Expert Opinion on Medical Diagnostics·Giovanna FinocchiaroFederico Cappuzzo
Apr 2, 2014·Expert Opinion on Drug Safety·Eleonora LucchiniGiampaolo Tortora
Jul 7, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Michaël DuruisseauxJacques Cadranel
Aug 26, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Howard L West, David H Garfield
Jan 31, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Ugo PastorinoFilippo De Marinis
Jan 22, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·William D TravisDavid Yankelewitz
Mar 5, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Thomas FongRamaswamy Govindan
Jul 4, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jacques CadranelUNKNOWN IFCT-0401 Trial Group
Feb 9, 2013·Seminars in Oncology·Madhava BaikadiGloria J Morris
Jul 28, 2012·The Annals of Thoracic Surgery·Usman AhmadDaniel J Boffa
Aug 4, 2010·Surgical Pathology Clinics·Lucian R Chirieac, Sanja Dacic
Jan 23, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Robert C DoebelePaul A Bunn
May 16, 2009·Clinical Lung Cancer·Winson Y CheungNatasha B Leighl
Feb 24, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Susana CedrésEnriqueta Felip
Jul 28, 2006·Clinical Lung Cancer·Jessica S DoningtonHeather A Wakelee
Aug 30, 2008·Critical Reviews in Oncology/hematology·Rossana BerardiStefano Cascinu
Sep 11, 2007·Cancer Treatment Reviews·Daniela D RosaAhmad Awada
Aug 14, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xiaoqing ZhangZhemin Zhang
Jan 18, 2007·Expert Opinion on Therapeutic Targets·Suresh Ramalingam, Chandra P Belani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
Howard WestSouthwest Oncology Group
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Vincent A MillerDavid H Johnson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Román Pérez-SolerPhilip Bonomi
The New England Journal of Medicine
Frances A ShepherdNational Cancer Institute of Canada Clinical Trials Group
© 2022 Meta ULC. All rights reserved